MarketInOut Stock Screener Log In | Sign Up
 

Illumina Inc

MIL • Healthcare • Diagnostics & Research • Quote as of 09/21/2026 16:09
Illumina Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeMIL
Market Capitalization31,808 mln
Float92.27 mln
Earnings Date10/30/2026

EPS

4.67
Stretched

P / E

45.18
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.67
Likely reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

0.89
Moderate leverage

Business Description

Illumina is a San Diego-based company, founded in 1998, that makes tools and technologies used to read and analyze DNA. Its products are used by hospitals, universities, government labs, and drug companies across six continents to support a wide range of work, from cancer research and rare disease studies to prenatal testing and consumer genetics. The company sells directly to customers and through distributors, and has notable partnerships with Labcorp and the Center for Data-Driven Discovery in Biomedicine to advance work in oncology and pediatric medicine.

Key Fundamentals

EPS4.67
P/E45.18
ROE32.04
ROIC15.24
ROA12.84
Interest Cover9.01
EBITDA, mln1,190
EV / EBITDA24.49
EV / EBIT30.47
Revenue, mln3,863
EV / Revenue7.55

Quote Details

Last 215.80
Change 0 (0%)
Open 211.00
Volume 12
Turnover 2,589.6
Average Volume 30.81

Financial Ratios

Pre-Tax Profit Margin23
Current Ratio1.80
Price / Book11.47
Price / Tangible Book28.44
Price / Free Cash Flow35.55
Debt / Equity0.89
Price / Sales7.36
PEG Ratio2.70

Financial Strength

Altman Z-Score6.57
Piotroski F-Score 6 / 9
Beneish M-Score-2.67
Price to Intrinsic Value4.40
Price to Graham Number7.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 21.82% 99 / 100   
1 Month 20.42% 95 / 100   
2 Months 92.47% 99 / 100   
6 Months 179% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us